Cargando…
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
CCNE1 gene amplification is present in 15-20% ovary tumor specimens. Here, we showed that Cyclin E1 (CCNE1) was overexpressed in 30% of established ovarian cancer cell lines. We also showed that CCNE1 was stained positive in over 40% of primary ovary tumor specimens regardless of their histological...
Autores principales: | Yang, Liu, Fang, Dongdong, Chen, Huijun, Lu, Yiyu, Dong, Zheng, Ding, Han-Fei, Jing, Qing, Su, Shi-Bing, Huang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673230/ https://www.ncbi.nlm.nih.gov/pubmed/26204491 |
Ejemplares similares
-
ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017) -
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
por: Casimiro, Mathew C., et al.
Publicado: (2015) -
Cyclin E1-CDK 2, a potential anticancer target
por: Fang, Dongdong, et al.
Publicado: (2016) -
Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics
por: Choudhary, Gaurav S., et al.
Publicado: (2015) -
Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)